https://tiefenbacher-pharmaceuticals.com/2024/05/08/tiefenbacher-api-ingredients-offers-custom-synthesis-of-intermediates-apis/
https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/
https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/
https://tiefenbacher-pharmaceuticals.com/2023/09/27/launch-tiefenbacher-pharmaceuticals-generic-version-teriflunomide/
https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/
https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/
https://tiefenbachergroup.com/2023/02/25/tiefenbacher-groups-manufacturing-sites-have-been-successfully-registered-by-the-united-arab-emirates-ministry-of-health/
https://tiefenbachergroup.com/2022/12/01/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-psoriasis-medication-apremilast-in-canada/
https://tiefenbacher-api.com/2021/06/22/supply-of-controlled-substances/